Skip to main content

Navigation group

Type at least 3 characters
1,306 articles

Articles

Clinical Trial

Published on 29 Aug 2023

Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial

in Intensive Care Medicine and Anesthesiology

  • Cécile Pochon
  • Caroline Laroye
  • Antoine Kimmoun
  • Loic Reppel
  • Adéle Dhuyser
  • Hélène Rousseau
  • Mélanie Gauthier
  • Nadine Petitpain
  • Jean-François Chabot
  • Simon Valentin
Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial
Frontiers in Medicine
doi 10.3389/fmed.2023.1224865
  • 1,881 views
  • 2 citations